MatthewErikTenoldMD

Hematologic Oncology

Associate Physician Diplomat / Assistant Clinical Professor

Dr. Tenold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of California DavisChief Fellow, Hematology & Oncology, 2020 - 2021
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2018 - 2021
University of California Davis HealthResidency, Internal Medicine, 2015 - 2021
Albany Medical CollegeClass of 2015

PubMed

27 citations
Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma.
Matthew E. Tenold, Praful Ravi, Monika Kumar, I. Alex Bowman, Hans J. Hammers
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2020-04-02
36 citations
Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center.
Matthew E. Tenold, Benjamin N Moskoff, David J. Benjamin, Rasmus T. Hoeg, Aaron S. Rosenberg
Frontiers in Oncology. 2021-03-11
2 citations
An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.
Tamer Othman, Matthew E. Tenold, Benjamin N Moskoff, Tali Azenkot, Brian A. Jonas
Expert Review of Hematology. 2021-06-15

Books/Book Chapters

ASCO Education
Chapter: Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma
Matthew Tenold, MD; Praful Ravi, MD; Monika Kumar, MD; Alex Bowman, MD; Hans Hammers, MD, PhD ; Toni K. Choueiri, MD ; and Primo N. Lara Jr., MDAmerican Society of Clinical OncologyEdition 2020,2020

Abstracts/Posters

Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center
Matthew Tenold, MD BS, Benjamin Moskoff, PharmD, David Benjamin, MD, Brian A. Jonas, MD PhD, American Society of Hematology, San Diego, 11/29/2018
Retrospective Analysis of Adult Relapsed and Refractory Acute Leukemia Patients Treated with FLAG at a Comprehensive Cancer Cente
Matthew Tenold, MD, Benjamin Moskoff, PharmD, Rajeev Krishnan, MD, Aaron Seth Rosenberg, MD, Brian A Jonas, MD PhD, American Society of Hematology, Atlanta, GA, 12/7/2017